Last edition
News about "Lupin News"
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
Global pharma major Lupin Limited announced the achievement of key milestones for Lupin's MEK inhibitor compound (LNP3794) that is planned for development by Boehringer Ingelheim in combination as potential targeted therapy for patients with difficult-to-treat cancers
Lupin News | 27/05/2021 | By Darshana | 165
Lupin's Nagpur Facility Receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) after closure of the U.S. FDA inspection of its Nagpur, India facility. The inspection for the facility was carried out by the U.S. FDA between January 6, 2020 and January 10, 2020
Lupin News | 13/04/2020 | By Darshana | 586
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy